Note: the following material is for personal use only see below for



Download 3.95 Mb.
Page63/73
Date30.04.2018
Size3.95 Mb.
#47014
1   ...   59   60   61   62   63   64   65   66   ...   73

Spherocytosis


Primary hereditary spherocytosis: abnormal cytoskeletal protein (spectrin) (AD)

Secondary: autoimmune hemolysis

Findings: splenomegaly / increase in MCHC / may have normal appearing peripheral smear Diagnosis: osmotic fragility test

Treatment: splenectomy curative

RBC infection


malaria, Carrion’s disease, babesiosis, C. perfringens sepsis
March hemoglobinuria

massive intravascular hemolysis



Hemoglobinopathy


Hemoglobinopathy is abnormal structure of a globin chain
Physiology
Increased O2 affinity

elevated erythropoietin, erythrocytosis


Decreased O2 affinity

blue Hb > 5 g/dL leads to cyanosis


Methemoglobinemia

Causes: oxidizing compounds (nitrites, dapsone, local anesthetics, some anti-malarials, various chemicals: anilines, nitrosohydrocarbons)

Mechanism: O2 saturation curve shifted to left (too much Fe3+) or HbM / also caused by NADH-diaphorase deficiency (used to reduce circulating metheme)

Labs: elevated blood levels of HbM, peripheral smear (Heinz bodies, bite cells)

Presentation: cyanosis, gray-brown cyanosis or brownish discoloration of patient’s skin (at levels of 15-20%) and blood, hemolysis, tachycardia, tachypnea, lactic acidosis (levels > 45%)

  • O2 sats or pulse oximetry will be in 80’s (or normal) in spite of normal PaO2 (because the oxygen is in the blood, just not delivering to tissues properly)

Treatment: 100% O2, can give IV methylene blue for levels > 30% or symptomatic or evidence of ischemia, in severe cases consider exchange transfusion and/or hyperbaric O2
Unstable Hb (Heinz body anemia)

RBC becomes rigid, lysed by RE system / Heinz bodies seen with supravital dye



Sickle Cell Disease (HbS)


Genetics: valine as 6th amino acid on B-chain / masked for 6 months by HbF (a2d2) / alpha thalassemia carriers have lower MCHC and less severe course / HPFH (hereditary persistence of HbF) also lessens severity / electrophoresis (not solubility) to distinguish trait

Mechanism: deoxy-HbS forms tactoids causing sickling, dehydration at cellular level (as well as circulatory), activated platelets release thrombospondin which binds sickled RBCs

Triggers: deoxygenation, acidosis, dehydration, venous stasis, variations in body temperature / physical, emotional stress also a trigger

Presentation: anemia, jaundice, cholelithiasis, aplastic crisis, hemolytic crisis, dactylitis, leg ulcers, priapism, renal papillary necrosis, infarctive crisis, sequestration crisis (sudden pooling of RBC in RES, common COD in young patients / autosplenectomy usually complete before age 5, Sickle C and thalassemias may have splenic sequestration into adulthood

Complications:

  • Heme: hemolytic anemia, can have aplastic crisis, channel defects give target cells, congestive heart failure

  • Renal: nephrotic syndrome, progressive renal failure (decreased erythropoietin), isosthenuria, mild nitrogen retention, inability to concentrate urine, painless hematuria (also sickle cell trait)

  • GI: choledocholithiasis (mimic gall bladder pain), cholecystitis

  • Infections/Immune compromise

    • cellular immunity depressed, B-cell antibody production depressed, splenectomy (allows increased susceptibility to encapsulated organisms)

    • increased UTI (commonly precipitates crises / UTI also increased with sickle trait)

    • pneumonia (esp. mycoplasma)

    • osteomyelitis (S. aureus, Salmonella)

    • abscesses

  • Infarcts/hemorrhages – more common in children / can involve large veins

    • Bone: fish-mouth vertebrae (biconcave), expansion of bone marrow, aseptic necrosis (head of femur), chronic leg ulcers

    • CNS: stroke (can necessitate blood transfusion to decrease viscosity), cognitive (silent infarcts), sub-arachnoid hemorrhage and seizures (breakdown product of Demerol also causes seizures)

    • Eye: retinopathy, vitreous hemorrhages, retinal detachment (blindness) / risk increases with age (vascular)

    • hepatic infarcts, icterus [pic]

    • papillary necrosis

    • priapism

Labs:

CBC: Hgb 7-10 (rarely higher than 10) / 5 or less suggests associated G6PD or folate deficiency / total WBC 15-20 / reticulocytosis (except in aplastic crisis) / macrocytosis (many young RBC’s) [pic]

peripheral smear: splenic dysfunction  sideroblasts, target cells, Howell jolly bodies [pic]

LDH is useful to validate presence of hemolytic state

Diagnostic studies:

newborn screening / 99% of sickle cell patients present before age 1 anyway

metabisulfite test: will show sickling in blood specimen of any patient with HbS or sickle cell trait or HbC

monitor HBS levels (predict crisis frequency)

monitor blood counts (based on clinical assessment)

pulmonary function testing – reduce ACS # / determine need for IS and ß-agonists

transcranial Doppler (predict stroke risk)

Treatment:

Note: avoid use of CT contrast (may worsen crisis and cause major problems)

Fluids: replace fluid liberally (rule out concentrating deficits)

cellular hydration: Mg salts, Clotrimazole (small doses inhibit Gados channel)

Other: bed rest, O2, ? steroids, IVIG

Pain control: morphine, meperidine, hydromorphone

Prophylaxis (with appropriate antibiotics) until ready for Pneumococcal vaccine


  • folate / L-arginine (under investigation)

  • ACE inhibitors reduce proteinuria, slow progression of renal failure [ongoing studies]

Induction of HgF

  • hydroxyurea (3-4 wk onset, also increases cell volume, decreases granulocytes) [usually only used in severe cases] 10-15 mg/kg/day q am 6-8 wks / check blood counts, increase dose if necessary / consider reasons for failure of HgF induction – acceptable myelotoxicity plat > 80,000 WBC > 20,000 / 1/3 respond to hydroxyurea [6 months – 1yr onset]

  • short chain fatty acids (may work faster)

Transfusion: acute/chronic anemia / renal failure / many other needs / do NOT transfuse just to elevate Hg/Hct unless indicated (uncomplicated surgery, pregnancy, anemia-induced end-organ ischemia, anemia-induced pain, to decrease viscosity with ongoing thrombosis, stroke)

Course: 60% at least one episode per year / 1-2% have constant pain ( > 6 episodes/yr)

Prognosis: peak mortality: 6 months – 1 yr / late adolescent, young adults
Acute chest syndrome
Definition: new pulmonary infiltrate on CXR, fever, respiratory symptoms (can be due to pneumonia, PE, vaso-occlusion)

Incidence: children and young adults (4 fold greater incidence), often occurs perioperatively

Causes: bone marrow embolism, fat embolism, infection (14% bacteremic, chlamydia >

mycoplasma > RSV)

older patients w/ ACS  more pain, more mortality



Treatment:

Oxygen (give oxygen even if sats okay because it reduces sickling of RBC’s)

Bronchodilators

Antibiotics (must cover typical and atypicals, use macrolides or quinolones)

Transfusion for PaO2 drop of more than 10% or PaO2 < 70 / exchange transfusion if Hct already ≥ 30

(Careful) hydration (give fluid, but not so much to cause pulmonary edema)

Long term – consider hydroxyurea


aplastic crisis

most often from parvovirus B19 / usually self-limiting but may require transfusion


HbC (excellent prognosis)

mutation on B chain (lysglu) / crystalloids (pathognomonic, rarely seen in smear) / many target cells (codocytes) / retinal vascular lesions worse in SC than SS patient / tend to have enlarged spleen rather than asplenia




Download 3.95 Mb.

Share with your friends:
1   ...   59   60   61   62   63   64   65   66   ...   73




The database is protected by copyright ©ininet.org 2024
send message

    Main page